Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity-Reference-Cited by-同舟云学术

Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity

Published:1998-12 Issue:12 Volume:59 Page:776-782
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Alexander Jeff,Del Guercio Marie-France,Fikes John D,Chesnut Robert W,Chisari Francis V,Chang Kyong-Mi,Appella Ettore,Sette Alessandro

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference28 articles.

1. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection;Vitiello;J Clin Invest,1995

2. HLA-binding supermotifs predict broadly crossreactive cytotoxic T lymphocyte responses in patients with acute hepatitis;Bertoni;J Clin Invest,1997

3. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection;Livingston;J Immunol,1997

4. Hepatitis B virus immunopathogenesis;Chisari;Annu Rev Immunol,1995

5. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection;Rehermann;J Clin Invest,1996

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus;Current Computer-Aided Drug Design;2019-03-12

2. Creating Datasets for Bioinformation;Bioinformation Discovery;2018

3. Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome;Human Vaccines & Immunotherapeutics;2014-06-24

4. A Novel HLA-A2–restricted CTL Epitope of Tumor-associated Antigen L6 can Inhibit Tumor Growth In Vivo;Journal of Immunotherapy;2012-04

5. Creating Datasets;Bioinformation Discovery;2009